OSE Immunotherapeutics S.A.

OSE Immunotherapeutics S.A.

ORPOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$40.76M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
OSE Immunotherapeutics S.A.OSE Immunotherapeutics S.A.-1--1%-1.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$40.76 Million
Enterprise Value$59.77 Million
Earnings per Share$-
Beta0.85
Outstanding Shares-

Return

Return on Equity-0.93%ROE
Return on Assets-0.33%
Return on Invested Capital-6.01%

Valuation & Multiples

P/E Ratio-1.03P/E Ratio
PEG-7.06PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.69
Enterprise Value to EBIT-18.57
Enterprise Value to Net Income-235
Total Debt to Enterprise0.61
Debt to Equity1.34Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 31, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About OSE Immunotherapeutics S.A.

64 employees
CEO: Marc Le Bozec

Headquartered in Nantes, France, OSE Immunotherapeutics S.A. is a biotechnology company dedicated to pioneering immunotherapies. Its research and development efforts are concentrated on modulating immune responses, specifically in the do...